Scilex Holding Company announces a $13.2 million early payment on its Oramed Note, reducing remaining balance due March 2025.Quiver AI SummaryScilex Holding Company, based in Palo Alto, California, has...
Scilex Holding Company closed a direct stock offering, raising approximately $17 million for corporate purposes and product development.Quiver AI SummaryScilex Holding Company has successfully closed a...
Scilex Holding Company announces a $17 million stock offering for growth and development in pain management therapies.Quiver AI SummaryScilex Holding Company announced a definitive agreement with institutional...
KDS2010 Phase 2 trial evaluates safety and efficacy for obesity treatment; positive Phase 1 results reported.Quiver AI SummaryScilex Bio has announced an ongoing Phase 2 clinical trial for KDS2010, a novel...